Form 8-K - Current report:
SEC Accession No. 0001728117-25-000043
Filing Date
2025-06-25
Accepted
2025-06-25 16:01:12
Documents
12
Period of Report
2025-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K goss-20250625.htm   iXBRL 8-K 45511
  Complete submission text file 0001728117-25-000043.txt   165029

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20250625.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20250625_lab.xml EX-101.LAB 22532
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20250625_pre.xml EX-101.PRE 13051
14 EXTRACTED XBRL INSTANCE DOCUMENT goss-20250625_htm.xml XML 2858
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 251073587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)